Inhibition of the Inositol Kinase Itpkb Augments Calcium Signaling in Lymphocytes and Reveals a Novel Strategy to Treat Autoimmune Disease

• Andrew T. Miller ,

  * E-mail: amiller@gnf.org

  Affiliation The Genomics Institute of the Novartis Research Foundation (GNF), San Diego, California, United States of America

  ⨯
• Carol Dahlberg,

  Affiliation The Genomics Institute of the Novartis Research Foundation (GNF), San Diego, California, United States of America

  ⨯
• Mark L. Sandberg,

  Affiliation The Genomics Institute of the Novartis Research Foundation (GNF), San Diego, California, United States of America

  ⨯
• Ben G. Wen,

  Affiliation The Genomics Institute of the Novartis Research Foundation (GNF), San Diego, California, United States of America

  ⨯
• Daniel R. Beisner,

  Affiliation The Genomics Institute of the Novartis Research Foundation (GNF), San Diego, California, United States of America

  ⨯
• John A. H. Hoerter,

  Affiliation The Genomics Institute of the Novartis Research Foundation (GNF), San Diego, California, United States of America

  ⨯
• Albert Parker,

  Affiliation The Genomics Institute of the Novartis Research Foundation (GNF), San Diego, California, United States of America

  ⨯
• Christian Schmedt,

  Affiliation The Genomics Institute of the Novartis Research Foundation (GNF), San Diego, California, United States of America

  ⨯
• Monique Stinson,

  Affiliation The Genomics Institute of the Novartis Research Foundation (GNF), San Diego, California, United States of America

  ⨯
• Jacqueline Avis,

  Affiliation The Genomics Institute of the Novartis Research Foundation (GNF), San Diego, California, United States of America

  ⨯
• Cynthia Cienfuegos,

  Affiliation The Genomics Institute of the Novartis Research Foundation (GNF), San Diego, California, United States of America

  ⨯
• Mark McPate,

  Affiliation Novartis Pharmaceuticals UK Limited, Respiratory Disease Area, Horsham, West Sussex, United Kingdom

  ⨯
• Pamela Tranter,

  Affiliation Novartis Pharmaceuticals UK Limited, Respiratory Disease Area, Horsham, West Sussex, United Kingdom

  ⨯
• Martin Gosling,

  Affiliation Novartis Pharmaceuticals UK Limited, Respiratory Disease Area, Horsham, West Sussex, United Kingdom

  ⨯
• Paul J. Groot-Kormelink,

  Affiliation Novartis Institutes for Biomedical Research, Musculoskeletal Disease Area, Basel, Switzerland

  ⨯
• Janet Dawson,

  Affiliation Novartis Pharma AG, Novartis Institutes for Biomed. Research, Basel, Switzerland

  ⨯
• Shifeng Pan,

  Affiliation The Genomics Institute of the Novartis Research Foundation (GNF), San Diego, California, United States of America

  ⨯
• Shin-Shay Tian,

  Affiliation The Genomics Institute of the Novartis Research Foundation (GNF), San Diego, California, United States of America

  ⨯
• H. Martin Seidel,

  Affiliation The Genomics Institute of the Novartis Research Foundation (GNF), San Diego, California, United States of America

  ⨯
•  [ ... ],
• Michael P. Cooke

  Affiliation The Genomics Institute of the Novartis Research Foundation (GNF), San Diego, California, United States of America

  ⨯
• [ view all ]
• [ view less ]